Compass Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
OMER
Omeros Corporation |
$9.36 | $664.28 M | -4.64 | 202 |
OCGN
Ocugen, Inc. |
$1.42 | $445.06 M | -6.48 | 95 |
MNPR
Monopar Therapeutics Inc. |
$71.71 | $474.46 M | -17.93 | 14 |
LXRX
Lexicon Pharmaceuticals, Inc. |
$1.18 | $426.99 M | -6.18 | 103 |
KALV
KalVista Pharmaceuticals, Inc. |
$16.02 | $810.51 M | -4.07 | 150 |
GOSS
Gossamer Bio, Inc. |
$3.56 | $816.31 M | -5.21 | 144 |
FULC
Fulcrum Therapeutics, Inc. |
$12.32 | $673.69 M | -10.92 | 45 |
FDMT
4D Molecular Therapeutics, Inc. |
$8.34 | $390.90 M | -2.23 | 227 |
CRVS
Corvus Pharmaceuticals, Inc. |
$7.66 | $570.52 M | -14.15 | 31 |
BCYC
Bicycle Therapeutics plc |
$7.04 | $486.06 M | -1.94 | 305 |